FDA: Baxter, Salix should revise warning labels

03/23/2008 | Chicago Tribune (tiered subscription model) · Yahoo!

The FDA on Friday recommended new warnings for pediatric use of Suprane, Baxter International's inhaled anesthetic, and Colazal, Salix Pharmaceuticals Ltd.'s anti-inflammatory drug. The agency said Suprane should address cardiac arrest risk following three reported cases among children, while Colazal should have warnings on heart and lung risks that other drugs in the same class carry.

View Full Article in:

Chicago Tribune (tiered subscription model) · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA